ES2545187T3 - Empleo del hidrolizado de lisozima conteniendo triptófano para disminuir el apetito durante o después de situaciones de estrés - Google Patents

Empleo del hidrolizado de lisozima conteniendo triptófano para disminuir el apetito durante o después de situaciones de estrés Download PDF

Info

Publication number
ES2545187T3
ES2545187T3 ES11761592.2T ES11761592T ES2545187T3 ES 2545187 T3 ES2545187 T3 ES 2545187T3 ES 11761592 T ES11761592 T ES 11761592T ES 2545187 T3 ES2545187 T3 ES 2545187T3
Authority
ES
Spain
Prior art keywords
stressful situations
hydrolyzate containing
reduce appetite
containing tryptophan
lysozyme hydrolyzate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11761592.2T
Other languages
English (en)
Inventor
Cindy Gerhardt
Joris Kloek
Rob Markus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Application granted granted Critical
Publication of ES2545187T3 publication Critical patent/ES2545187T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)

Abstract

Empleo no terapéutico de una composición que comprende un hidrolizado de lisozima y tiene un ratio Trp / LNAA superior a 0,1, para disminuir el ansia de comer o el apetito durante o después de una situación de estrés.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES11761592.2T 2010-10-05 2011-09-28 Empleo del hidrolizado de lisozima conteniendo triptófano para disminuir el apetito durante o después de situaciones de estrés Active ES2545187T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10186571 2010-10-05
EP10186571 2010-10-05
PCT/EP2011/066801 WO2012045617A1 (en) 2010-10-05 2011-09-28 Peptides containing tryptophan

Publications (1)

Publication Number Publication Date
ES2545187T3 true ES2545187T3 (es) 2015-09-09

Family

ID=44719928

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11761592.2T Active ES2545187T3 (es) 2010-10-05 2011-09-28 Empleo del hidrolizado de lisozima conteniendo triptófano para disminuir el apetito durante o después de situaciones de estrés

Country Status (9)

Country Link
US (1) US9629890B2 (es)
EP (1) EP2624850B1 (es)
JP (1) JP6041242B2 (es)
KR (1) KR101957531B1 (es)
CN (1) CN103153326B (es)
BR (1) BR112013008096A2 (es)
ES (1) ES2545187T3 (es)
PL (1) PL2624850T3 (es)
WO (1) WO2012045617A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2079847B1 (en) 2006-11-02 2012-03-07 DSM IP Assets B.V. Use of lysozyme hydrolysates containing tryptophan
EP2624850B1 (en) * 2010-10-05 2015-07-08 DSM IP Assets B.V. Use of tryptophan-rich lysozyme hydrolysate for decreasing appetite during or after stress
EP2701716B1 (en) 2011-04-28 2017-11-01 DSM IP Assets B.V. Protein hydrolysates as agents for overcoming addiction
NZ702486A (en) * 2012-11-02 2019-06-28 Dsm Ip Assets Bv Use of tryptophan rich protein hydrolysates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02279700A (ja) 1989-04-19 1990-11-15 Asahi Chem Ind Co Ltd 高トリプトファン含有ペプチド
DE4130284A1 (de) 1991-09-12 1993-03-18 Willi Prof Dr Med Habil Heine Verfahren zur herstellung biologisch hochwertiger nahrungseiweisse
IL127684A0 (en) * 1996-07-17 1999-10-28 Nicada Inc Composition for appetite suppression
US6579899B1 (en) * 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
ATE357454T1 (de) 2000-12-06 2007-04-15 Campina Nederland Holding Bv Verfahren zur herstellung tryptophanreicher peptide
EP1599215B1 (en) 2003-02-07 2010-08-18 Campina B.V. Use of tryptophan rich peptides from whey protein hydrolysate for treating overweight and obesity
US7064104B2 (en) * 2003-06-13 2006-06-20 The Procter & Gamble Company Methods of managing the symptoms of premenstrual syndrome
US20050089546A1 (en) * 2003-09-16 2005-04-28 Dick Wurtman Compositions and methods comprising complex carbohydrate and alpha-lactalbumin
EP2079847B1 (en) * 2006-11-02 2012-03-07 DSM IP Assets B.V. Use of lysozyme hydrolysates containing tryptophan
CN101535494B (zh) * 2006-11-02 2014-04-09 帝斯曼知识产权资产管理有限公司 含有色氨酸的肽
JP5493195B2 (ja) 2008-04-29 2014-05-14 ディーエスエム アイピー アセッツ ビー．ブイ． 炭水化物およびトリプトファン含有ペプチドを含む組成物
CN102076228B (zh) 2008-04-29 2016-08-03 帝斯曼知识产权资产管理有限公司 与肽结合的色氨酸和与多肽结合的色氨酸的混合物
EP2624850B1 (en) * 2010-10-05 2015-07-08 DSM IP Assets B.V. Use of tryptophan-rich lysozyme hydrolysate for decreasing appetite during or after stress

Also Published As

Publication number Publication date
BR112013008096A2 (pt) 2016-08-09
KR20130139972A (ko) 2013-12-23
CN103153326B (zh) 2015-08-19
EP2624850A1 (en) 2013-08-14
EP2624850B1 (en) 2015-07-08
CN103153326A (zh) 2013-06-12
US20130296232A1 (en) 2013-11-07
PL2624850T3 (pl) 2015-11-30
JP6041242B2 (ja) 2016-12-07
JP2013541540A (ja) 2013-11-14
WO2012045617A1 (en) 2012-04-12
KR101957531B1 (ko) 2019-03-12
US9629890B2 (en) 2017-04-25

Similar Documents

Publication Publication Date Title
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2527242T3 (es) Composiciones que comprenden un germinante y un agente antimicrobiano
ES2637421T3 (es) Composiciones tópicas que comprenden variantes de pliegue-OB
CL2018000983A1 (es) Composiciones y métodos para producir cetosis elevada y sostenida (divisional de solicitud n°02802-2015).
ES2620754T3 (es) Uso de 5-androstano (alquil)-3,5,6-triol en la preparación de fármacos neuroprotectores
CL2016002023A1 (es) “compuestos derivados de benzoato-4-(amidoamino)- sustituido con un grupo oxazol dicarboxilico, inhibidores de enteropeptidasa; composición farmacéutica que los comprende; y su uso en el tratamiento de obesidad y diabetes mellitus”. pct
NI201600043A (es) Ácidos grasos octanoico, nonanoico y decanoico con un adulticida piretroide
ES2596248T3 (es) N-Carbamoilputrescina para mejorar la síntesis de proteínas musculares
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
EA201001845A1 (ru) Высокоэффективный антиокислитель на основе трегалулозы
ES2508165T3 (es) Lactoferrina y sustancia blanca
EA201291295A1 (ru) Высокоувлажняющая высокодисперсная эмульсия
CL2015003584A1 (es) Compuestos nuevos para el tratamiento del cáncer.
ES2510403T3 (es) Composición antioxidante, sinérgica
MX2019013251A (es) Una composicion nutricional para usarse para mejorar la atencion y/o reducir la impulsividad.
ES2582854T3 (es) Uso de un agente para ensilaje para el tratamiento de remolachas no fragmentadas
ES2561813T3 (es) Aplicación tópica de nimesulida y tiocolchicósido
ES2536842T3 (es) Composición farmacéutica para el tratamiento del cáncer
RU2013142539A (ru) Ароматические полиэфиры
CL2016001008A1 (es) Formulaciones de inyección con base en aceite de sésamo.
ES2605454T3 (es) Métodos para reducir la neurodegeneración
ES2478692A1 (es) Formulaciones líquidas de carbocisteína de propiedades mejoradas
RU2014118884A (ru) Средство для снижения алкогольной мотивации при алкогольной зависимости
ES1135465U (es) Motor de cilindros pivotantes
TWD158118S (zh) 影像投影燈具